Royalty Pharma plc (RPRX) Reports Q4 results

Royalty Pharma plc (NASDAQ: RPRX) reported Q4 Revenue for the quarter at $622 million versus the consensus estimate of $796.14 million.

For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• QumulusAI signs 7-year Atlanta data center deal for 3.75 MW
• BofA Securities Starts ProQR Therapeutics N.V. (PRQR) at Buy